Literature DB >> 18579024

Neurocritical care of patients with central nervous system infections.

Andreas H Kramer1, Thomas P Bleck.   

Abstract

Bacterial meningitis and viral encephalitis are life-threatening infections with high mortality rates. Patients who survive these infections often remain permanently disabled. Potential neurologic complications requiring careful attention include impaired consciousness, elevated intracranial pressure (ICP), hydrocephalus, stroke, and seizures. Systemic complications are also common and are frequently the immediate cause of death. The importance of emergent administration of appropriate antimicrobial therapy cannot be overstated, but critical care of these patients should focus not only on treatment of the underlying infection and its immediate complications but also on minimizing secondary brain injury. Given the increasing complexity of the diagnostic and therapeutic modalities available to manage central nervous system (CNS) infections, the involvement of neurocritical care units and neurointensivists may be particularly helpful in improving outcomes. It is our opinion that ICP measurement should be strongly considered in selected patients with CNS infections, particularly those who are comatose. Treatments for intracranial hypertension, specifically in the setting of CNS infection, are described in this paper. For bacterial meningitis, intravenous dexamethasone should be administered, beginning concomitantly with the initial dose of antibiotics, at least until Streptococcus pneumoniae can be excluded as a pathogen. Clinicians should maintain a high index of suspicion for nonconvulsive seizures. Deterioration in neurologic status should also prompt early use of CT or magnetic resonance angiography and venography to exclude cerebrovascular complications.

Entities:  

Year:  2008        PMID: 18579024     DOI: 10.1007/s11940-008-0022-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  52 in total

1.  Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis.

Authors:  J H Tureen; M G Täuber; M A Sande
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 2.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Dependency of cerebral blood flow on mean arterial pressure in patients with acute bacterial meningitis.

Authors:  K Møller; F S Larsen; J Qvist; J H Wandall; G M Knudsen; I E Gjørup; P Skinhøj
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

4.  A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985.

Authors:  P G Kennedy
Journal:  Q J Med       Date:  1988-07

Review 5.  Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline.

Authors:  Alfred T Ogden; Stephan A Mayer; E Sander Connolly
Journal:  Neurosurgery       Date:  2005-08       Impact factor: 4.654

6.  Brain infarcts in adults with bacterial meningitis.

Authors:  W Weststrate; A Hijdra; J de Gans
Journal:  Lancet       Date:  1996-02-10       Impact factor: 79.321

7.  Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.

Authors:  Tom Solomon; Nguyen Minh Dung; Rachel Kneen; Le Thi Thu Thao; Mary Gainsborough; Ananda Nisalak; Nicholas P J Day; Fenella J Kirkham; David W Vaughn; Shelagh Smith; Nicholas J White
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097

View more
  4 in total

1.  Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies.

Authors:  Debra C Quenelle; Bernhardt Lampert; Deborah J Collins; Terri L Rice; George R Painter; Earl R Kern
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

2.  Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats.

Authors:  M A Galic; K Riazi; A K Henderson; S Tsutsui; Q J Pittman
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

3.  Neuron-Specific Enolase Is Correlated to Compromised Cerebral Metabolism in Patients Suffering from Acute Bacterial Meningitis; An Observational Cohort Study.

Authors:  Jiri Bartek; Eric Peter Thelin; Per Hamid Ghatan; Martin Glimaker; Bo-Michael Bellander
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

4.  Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study.

Authors:  Martin Glimåker; Bibi Johansson; Halla Halldorsdottir; Michael Wanecek; Adrian Elmi-Terander; Per Hamid Ghatan; Lars Lindquist; Bo Michael Bellander
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.